login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
ANGIODYNAMICS INC (ANGO) Stock News
USA
- NASDAQ:ANGO -
US03475V1017
-
Common Stock
11.74
USD
+0.67 (+6.05%)
Last: 10/2/2025, 8:00:01 PM
11.42
USD
-0.32 (-2.73%)
After Hours:
10/2/2025, 8:00:01 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
ANGO Latest News, Press Relases and Analysis
All
Press Releases
17 hours ago - By: Chartmill
AngioDynamics Inc (NASDAQ:ANGO) Surpasses Q1 Earnings Estimates and Raises Fiscal 2026 Outlook
10 hours ago - By: Benzinga
- Mentions:
CAN
FPAY
ONDS
NVNI
...
Crude Oil Down 2%; Aspire Biopharma Shares Spike Higher
12 hours ago - By: The Motley Fool
Why Did AngioDynamics Stock Pop Today?
13 hours ago - By: Benzinga
What's Fueling The Momentum In AngioDynamics Stock?
17 hours ago - By: Zacks Investment Research
- Mentions:
EW
AngioDynamics (ANGO) Reports Q1 Loss, Tops Revenue Estimates
19 hours ago - By: AngioDynamics, Inc.
AngioDynamics Reports Fiscal Year 2026 First Quarter Financial Results; Med Tech Growth of 26.1% Drives Continued Momentum
15 days ago - By: AngioDynamics, Inc.
AngioDynamics to Report Fiscal 2026 First Quarter Results on October 2, 2025
23 days ago - By: Zacks Investment Research
- Mentions:
NTRB
Nutriband Inc. (NTRB) Reports Q2 Loss, Lags Revenue Estimates
a month ago - By: Zacks Investment Research
- Mentions:
PEN
Why Is Penumbra (PEN) Up 5% Since Last Earnings Report?
a month ago - By: Zacks Investment Research
- Mentions:
BSX
WST
MEDP
Reasons to Hold AngioDynamics Stock in Your Portfolio for Now
2 months ago - By: AngioDynamics, Inc.
AngioDynamics to Present at the Canaccord Genuity 45th Annual Growth Conference
2 months ago - By: AngioDynamics, Inc.
AngioDynamics Enrolls First Patient in AMBITION BTK Trial Advancing Treatment for Critical Limb Ischemia
2 months ago - By: AngioDynamics, Inc.
AngioDynamics Announces Publication of PRESERVE Study of NanoKnifeĀ® System for Prostate Tissue Ablation in European Urology
3 months ago - By: The Motley Fool
Why AngioDynamics Stock Popped, Then Dropped Today
3 months ago - By: Yahoo Finance
Why AngioDynamics Stock Popped, Then Dropped Today
3 months ago - By: AngioDynamics, Inc.
AngioDynamics Reports Strong Fiscal Year 2025 Fourth Quarter and Full Year Financial Results; Continued Execution Driving Accelerated, Profitable Growth
3 months ago - By: AngioDynamics, Inc.
AngioDynamics to Report Fiscal 2025 Fourth Quarter and Full-Year Financial Results on Tuesday, July 15, 2025
3 months ago - By: AngioDynamics, Inc.
AngioDynamics Announces First Patient Enrolled in RECOVER-AV Clinical Trial Evaluating AlphaVac F1885 System for Treatment of Acute Pulmonary Embolism
3 months ago - By: Zacks Investment Research
- Mentions:
SNN
CVS
ITGR
Smith+Nephew Stock May Gain From Strategic Deal With Standard Health
3 months ago - By: Zacks Investment Research
- Mentions:
ECL
CVS
ITGR
Here's Why You Should Retain Ecolab Stock in Your Portfolio Now
4 months ago - By: Yahoo Finance
- Mentions:
PBNC
ITGR
NRDS
MC
...
Meta Launches Opportunity Score to All Advertisers
4 months ago - By: Yahoo Finance
- Mentions:
MC
PBNC
ITGR
NRDS
...
Moelis names next CEO
4 months ago - By: Zacks Investment Research
- Mentions:
CVS
NVCR
ITGR
NVCR Stock Dips Despite Positive OS Data From Phase 3 PANOVA-3 Trial
Please enable JavaScript to continue using this application.